[{"Assets_0_Q3_USD":160207000.0,"CommonStockSharesOutstanding_0_Q3_shares":98367184.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-46477000.0,"NetIncomeLoss_1_Q3_USD":-15581000.0,"NetIncomeLoss_3_Q3_USD":-50148000.0,"StockholdersEquity_0_Q3_USD":135956000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]